Search

everythinglearnresearchcommunity

for

Search:↓

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

The study identified unique genes in hair follicle cells and their environment, suggesting these genes help organize cells for hair growth.

Women with PCOS have different levels of certain metabolites in their blood, which could help diagnose and predict the condition.

The research found new potential mechanisms in mouse hair growth by studying RNA interactions.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Turning white fat into brown-like fat could help fight obesity and type 2 diabetes.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

IL-17-producing γδ T cells help improve bone healing.

Increasing mir-302 turns human hair cells into stem cells by changing gene regulation and demethylation.